Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing

Throughout the global push to produce COVID-19 vaccines, pharma companies have frequently come under fire for unequal access to their shots. Oxfam, in a bid to force better access, has scored a series of wins in its effort to exact pricing and intellectual property information from Johnson & Johnson, Pfizer and Moderna.